Theravance Biopharma
TBPH
TBPH
93 hedge funds and large institutions have $320M invested in Theravance Biopharma in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $533M → $320M (-$213M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
93
Holding in Top 10
–
Calls
$291K
Puts
$53K
Top Buyers
| 1 | +$7.15M | |
| 2 | +$6.45M | |
| 3 | +$3.74M | |
| 4 |
First Manhattan
New York
|
+$3.35M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.65M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$14.4M | |
| 3 | -$10.5M | |
| 4 |
PC
Perry Capital
New York
|
-$9.99M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.1M |